Evidence map›Paper›PMID 42146849›Full record

ArticleDigital biomarkers

Methods for Wearable-Derived Pulse Rate Measures and Their Application to Modeling the Relationship between Pulse Rate and Motor Activity in Narcolepsy Type 1.

Eena Kosik-Rose, Raul Torres, Brian Tracey, Tina Olsson, Dmitri Volfson, Francesco Onorati, Marta Karas

Registry-linked trialAbstract read
In one paragraph

Article in Digital biomarkers. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05687903 (A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-861 for the Treatment of Narcolepsy With Cataplexy), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05687903 phase2completednot on this map

A Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-861 for the Treatment of Narcolepsy With Cataplexy (Narcolepsy Type 1)

TypeinterventionalSponsorTakedaRan2023 to 2023Enrolled112ConditionsNarcolepsy Type 1ArmsTAK-861, Placebo
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eena Kosik-RoseDepartment of Cognitive Sciences, University of California, San Diego, CA, USA.
Raul TorresTakeda Development Center Americas, Inc., Cambridge, MA, USA.
Brian TraceyTakeda Development Center Americas, Inc., Cambridge, MA, USA.
Tina OlssonTakeda Development Center Americas, Inc., Cambridge, MA, USA.
Dmitri VolfsonTakeda Development Center Americas, Inc., Cambridge, MA, USA.
Francesco OnoratiTakeda Development Center Americas, Inc., Cambridge, MA, USA.
Marta KarasTakeda Development Center Americas, Inc., Cambridge, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Narcolepsy type 1 (NT1) is a chronic, rare neurological disorder caused by loss of orexin neurons that disrupts the sleep-wake cycle. Current research suggests a link between orexin neuropeptide deficiency and heart rate regulation. Wrist-worn devices enable continuous monitoring of physiological data, including heart rate. We aim to effectively utilize wearables in clinical research by developing robust methodologies to address challenges including data artifacts and missing data. Methods: Empatica wrist-worn smartwatch data were collected for 2 weeks at baseline in the TAK-861-2001 randomized, phase 2 clinical trial (NCT05687903) from participants with NT1. Epoch-level (minute-level) pulse rate data were rigorously screened for artifacts. Daily pulse rate measures (24-h, daytime, and nighttime averages) were derived. Numerical experiments were conducted to evaluate the stability of daily measures as a function of the proportion of valid minute-level data within a given day. Mean pulse rate and motor activity daily measures and the association between the two were quantified using linear mixed-effects models. Results: Participants ( Conclusion: This work proposes a robust framework for preprocessing smartwatch pulse rate data for analyses in clinical research. The findings from our smartwatch data demonstrate a significant positive association between pulse rate and motor activity in participants with NT1 during a 2-week baseline period.

Indexed as

Heart rateMotor activityNarcolepsyPulse rateWearable device

Identifiers

PMID42146849
PMCPMC13175547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.